IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells
Human Cell · 20.06.2024 · 37 (5) · 1434-1445
DOI: 10.1007/s13577-024-01094-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, online erschienen am 20.06.2024. Verfasst von Jianbing Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Taiyuan, 036000, Shanxi, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, MicroRNAs, Cell Movement, NF-kappa B. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Shanxi Fundamental Research Program, National Natural Science Foundation of China, Postdoctoral Research Foundation of China.
Abstract (Originalsprache)
Human papillomavirus (HPV) infection is a major contributor to cervical cancer. Persistent HPV infection can trigger the expression of IL-32, yet the precise role of IL-32 in the occurrence and development of cervical cancer remains elusive. To investigate this, qRT‒PCR and western blotting were utilized to measure the mRNA and protein expression levels; bioinformatics analysis was used to screen differentially expressed miRNAs; wound healing and transwell assays were conducted to evaluate cell migration and invasion capabilities. Comparative analysis revealed significantly elevated IL-32 expression in cervical cancer tissues and cell lines compared to control groups. In SiHa and/or HeLa, overexpression of IL-32 and IL-32 exposure markedly upregulated miR-205, whereas its knockdown resulted in a substantial downregulation of miR-205. Furthermore, miR-205 also could significantly regulate the expression of IL-32 in HeLa and SiHa cells. Upregulation and downregulation of IL-32 led to a significant increase or decrease in NFκB expression, respectively. Treatment with BAY11-7082 (an NFκB inhibitor) notably decreased miR-205 expression but had no effect on IL-32 levels. qRT‒PCR and western blotting analyses demonstrated that both overexpression and underexpression of IL-32 and miR-205 significantly enhanced or reduced MMP2 and MMP9 expression in cervical cancer cells, respectively. Knockdown of IL-32 significantly inhibited the migration and invasion of HeLa and SiHa; conversely, treatment with rIL-32α and rIL-32γ notably promoted their migration and invasion. In brief, IL-32 is highly expressed via the formation of a positive regulatory loop with NFκB/miR-205, contributing to the persistence of inflammation and promoting the progression of cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Taiyuan, 036000, Shanxi, China.
- School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
- School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, 030001, Shanxi, China. lili_5076@sxmu.edu.cn.
- Departments of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Taiyuan, 036000, Shanxi, China. 2yuanhaomin@163.com.
Förderung
- Shanxi Fundamental Research Program
- National Natural Science Foundation of China
- Postdoctoral Research Foundation of China
Zitieren
APA
Liu, J., Yang, K., Lin, X., Xu, J., Cui, X., Hao, J., Wang, W., Wang, W., Li, L., & Hao, M. (2024). IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells. Human Cell, 37(5), 1434-1445. https://doi.org/10.1007/s13577-024-01094-7
Vancouver
Liu J, Yang K, Lin X, Xu J, Cui X, Hao J, et al. IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells. Human Cell. 2024;37(5):1434-1445. doi:10.1007/s13577-024-01094-7
BibTeX
@article{Liu2024,
author = {Liu, Jianbing and Yang, Kai and Lin, Xiaoyu and Xu, Jing and Cui, Xiaohua and Hao, Jianqing and Wang, Wei and Wang, Wenhao and Li, Li and Hao, Min},
title = {IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells},
journal = {Human Cell},
year = {2024},
volume = {37},
number = {5},
pages = {1434--1445},
doi = {10.1007/s13577-024-01094-7}
}
EUVIMED